| Announce Date | 10/29/2025 |
| EPS Normalized Actual | $0.29 (Beat by $0.0043) |
| EPS GAAP Actual | $0.29 (Beat by $0.0043) |
| Revenue Actual | $3.00344B |
| Revenue Surprise | Beat by $3003.44M |
| Announce Date | 10/01/2025 (Pre-Market) |
| EPS Normalized Estimate | $16.62084 |
| EPS GAAP Estimate | $16.62084 |
| Revenue Estimate | $3.240146502B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 2.465 | 12.39 | 2.40408 | 2.54668 | 3 |
| Dec 2028 | 110.61 | 0.28 | 106.29678 | 116.09193 | 6 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.29 | -18.04292 | 3.00344B | 6.99% | -305.36M |
| FQ2 2025 (Jun 2025) | 0.32 | -17.52301 | 3.06339B | 2.95% | -180.86M |
| FQ1 2025 (Mar 2025) | 0.29 | 0.29 | 2.87525B | 6.03% | 2875.25M |
| FQ4 2024 (Dec 2024) | 0.24 | 0.24 | 2.84531B | 11.56% | 2845.31M |
| FQ3 2024 (Sep 2024) | 0.28 | 0.28 | 2.79358B | 11.51% | 2793.58M |
| FQ2 2024 (Jun 2024) | 0.33 | 0.33 | 2.97312B | 15.42% | 2973.12M |
| FQ1 2024 (Mar 2024) | 13.09 | 13.09 | 2.70185B | 12.33% | 2701.85M |
| FQ4 2023 (Dec 2023) | 10.28 | 10.28 | 2.51632B | 13.34% | 2516.32M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
16.62084
Consensus Revenue Estimates
3.240146502B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.39147 | -- | 0.38702 | 0.39965 | 26 |
| FQ3 2027 (Sep 2027) | 0.46044 | -- | 0.45122 | 0.48131 | 9 |
| FQ2 2027 (Jun 2027) | 0.52948 | -- | 0.51887 | 0.55347 | 9 |
| FQ1 2027 (Mar 2027) | 0.42107 | -- | 0.41263 | 0.44015 | 16 |
| FQ4 2026 (Oct 2026) | 19.64008 | -- | 18.99358 | 20.51713 | 9 |
| FQ3 2026 (Jul 2026) | 22.17382 | 98.69 | 21.44392 | 23.16402 | 9 |
| FQ2 2026 (Jun 2026) | 21.60625 | 98.52 | 20.94442 | 22.42706 | 17 |
| FQ1 2026 (Mar 2026) | 17.33581 | 98.33 | 16.80479 | 17.99439 | 8 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 3.9B | -- | 3.86B | 3.96B | 12 |
| FQ3 2027 (Sep 2027) | 4.11B | -- | 4.04B | 4.25B | 9 |
| FQ2 2027 (Jun 2027) | 4.32B | -- | 4.25B | 4.47B | 9 |
| FQ1 2027 (Mar 2027) | 3.9B | -- | 3.84B | 4.03B | 9 |
| FQ4 2026 (Oct 2026) | 3.66B | -- | 3.57B | 3.79B | 9 |
| FQ3 2026 (Jul 2026) | 3.75B | 19.94 | 3.66B | 3.88B | 10 |
| FQ2 2026 (Jun 2026) | 3.69B | 17.09 | 3.61B | 3.8B | 13 |
| FQ1 2026 (Mar 2026) | 3.42B | 15.96 | 3.34B | 3.52B | 8 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
2
EPS # of in-lines
0
Revenue # of Beats
6
Revenue # of Misses
2
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 18.33292 | 0.29 | -18.04292 | -6221.7% |
| FQ2 2025 (Jun 2025) | 17.84301 | 0.32 | -17.52301 | -5475.94% |
| FQ1 2025 (Mar 2025) | 0.29 | 0.29 | 100% | |
| FQ4 2024 (Dec 2024) | 0.24 | 0.24 | 100% | |
| FQ3 2024 (Sep 2024) | 0.28 | 0.28 | 100% | |
| FQ2 2024 (Jun 2024) | 0.33 | 0.33 | 100% | |
| FQ1 2024 (Mar 2024) | 13.09 | 13.09 | 100% | |
| FQ4 2023 (Dec 2023) | 10.28 | 10.28 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $3.31B | $3B | $-305.36M | -10.17% |
| FQ2 2025 (Jun 2025) | $3.24B | $3.06B | $-180.86M | -5.9% |
| FQ1 2025 (Mar 2025) | $0B | $2.88B | $2875.25M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $2.85B | $2845.31M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $2.79B | $2793.58M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $2.97B | $2973.12M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $2.7B | $2701.85M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $2.52B | $2516.32M | 100% |